These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22230648)

  • 1. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
    De La Garza R; Newton TF; Haile CN; Yoon JH; Nerumalla CS; Mahoney JJ; Aziziyeh A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):141-6. PubMed ID: 22230648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
    De La Garza R; Mahoney JJ; Culbertson C; Shoptaw S; Newton TF
    Pharmacol Biochem Behav; 2008 Apr; 89(2):200-8. PubMed ID: 18207225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers.
    De La Garza R; Shoptaw S; Newton TF
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):729-41. PubMed ID: 18248689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers.
    De la Garza R; Yoon JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1827-30. PubMed ID: 21803113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.
    Verrico CD; Mahoney JJ; Thompson-Lake DG; Bennett RS; Newton TF; De La Garza R
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):223-33. PubMed ID: 24393456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.
    Kalechstein AD; Yoon JH; Croft DE; Jaeggi S; Mahoney JJ; De La Garza R
    Pharmacol Biochem Behav; 2011 Sep; 99(3):423-7. PubMed ID: 21624391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivastigmine does not alter cocaine-induced subjective effects or self-administration.
    Patel M; Verrico CD; De La Garza R
    Pharmacol Biochem Behav; 2019 Oct; 185():172758. PubMed ID: 31430484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.
    De La Garza R; Zorick T; London ED; Newton TF
    Drug Alcohol Depend; 2010 Jan; 106(2-3):173-80. PubMed ID: 19781865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.
    Reichel CM; See RE
    Psychopharmacology (Berl); 2010 Jun; 210(3):337-46. PubMed ID: 20352413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
    Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
    Nawata Y; Kitaichi K; Yamamoto T
    Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
    Pittenger ST; Barrett ST; Chou S; Bevins RA
    Behav Brain Res; 2017 Mar; 320():195-199. PubMed ID: 27939341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
    Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.
    De La Garza R; Zorick T; Heinzerling KG; Nusinowitz S; London ED; Shoptaw S; Moody DE; Newton TF
    Pharmacol Biochem Behav; 2009 Nov; 94(1):186-93. PubMed ID: 19698734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine Efficacy in Methamphetamine Dependence during Methadone Maintenance Therapy.
    Rabiey A; Hassani-Abharian P; Farhad M; Moravveji AR; Akasheh G; Banafshe HR
    Arch Iran Med; 2019 Dec; 22(12):692-698. PubMed ID: 31823620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.